MARKET

GUTS

GUTS

Fractyl Health
NASDAQ
0.6620
-0.0340
-4.89%
After Hours: 0.6938 +0.0318 +4.80% 18:15 08/13 EDT
OPEN
0.6895
PREV CLOSE
0.6960
HIGH
0.7000
LOW
0.6620
VOLUME
899.68K
TURNOVER
--
52 WEEK HIGH
2.445
52 WEEK LOW
0.3772
MARKET CAP
105.38M
P/E (TTM)
-0.4335
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), Progyny (PGNY) and Adicet Bio (ACET)
TipRanks · 1d ago
Morgan Stanley Keeps Their Hold Rating on Fractyl Health, Inc. (GUTS)
TipRanks · 2d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Rocket Pharmaceuticals (RCKT), Fractyl Health, Inc. (GUTS) and Theravance Biopharma (TBPH)
TipRanks · 2d ago
Fractyl Health, Inc. (GUTS) Receives a Buy from Bank of America Securities
TipRanks · 2d ago
Fractyl Health reports Q2 EPS (16c), consensus (14c)
TipRanks · 3d ago
Fractyl Health GAAP EPS of -$0.16 misses by $0.03
Seeking Alpha · 3d ago
Fractyl Health Q2 EPS $(0.16) Misses $(0.13) Estimate
Benzinga · 3d ago
Press Release: Fractyl Health Reports Second Quarter 2026 Financial Results and Business Updates
Dow Jones · 3d ago
More
About GUTS
Fractyl Health, Inc. is a metabolic therapeutics company. The Company is focused on developing new approaches to the treatment of metabolic diseases, including obesity and type 2 diabetes (T2D). The Company’s lead product candidate, Revita, is designed to remodel the duodenal lining via hydrothermal ablation (i.e. duodenal mucosal resurfacing) to reverse damage to intestinal nutrient sensing and signaling mechanisms caused by chronic high-fat and high-sugar diets that are a root cause of metabolic disease. The Revita clinical program is focused on patients living with obesity who want to maintain their weight loss after GLP-1 drug discontinuation. The Company’s Rejuva platform focuses on developing adeno-associated virus (AAV)-based, locally delivered gene therapies for the treatment of obesity and T2D. The Rejuva platform leverages advanced delivery systems and proprietary screening methods to identify and develop metabolically active gene therapy candidates targeting the pancreas.

Webull offers Fractyl Health Inc stock information, including NASDAQ: GUTS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GUTS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GUTS stock methods without spending real money on the virtual paper trading platform.